1-7 of 7
Christopher R. Cogle, M.D.
Close
Sort by
Journal Articles

Negative Correlation Between the Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) and Total Hospital Stay in Patients Who Underwent Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT)

Napoleon Santos, DO, Randy A. Brown, MD, Myron N Chang, PhD, Christopher R Cogle, M.D., John W. Hiemenz, MD, W. Stratford May, Jan S Moreb, MD, Maxim Norkin, MD, PhD, John R. Wingard, MD, Baldeep Wirk, MD, Jack W Hsu, MD
Journal: Blood
Blood (2011) 118 (21): 4462.
https://doi.org/10.1182/blood.V118.21.4462.4462
Published: 2011
Journal Articles

The Jak2 Kinase Inhibitor, G6, Reduces the Mutant Burden and Reverses Marrow Fibrosis in a Mouse Model of Jak2-V617F Mediated PMF,

Peter P. Sayeski, Ph.D., Annet Kirabo, Sung Park, Ph.D., Meghanath Gali, Mary Reinhard, DVM, DACLAM, Heather L Wamsley, Zhizhuang Joe Zhao, PhD, Kirpal S Bisht, Christopher R Cogle, M.D., Gyorgy M Keseru
Journal: Blood
Blood (2011) 118 (21): 3858.
https://doi.org/10.1182/blood.V118.21.3858.3858
Published: 2011
Journal Articles

Acute Myeloid Leukemia Cells Generate Leukemic Endothelial Cells with Leukemogenic Potential: Blood Vessels As Sanctuaries for Leukemia Relapse

Christopher R Cogle, M.D., Gerard J Madlambayan, PhD, Devorah C Goldman, Ph.D., Azzah Al Masri, Ronald P. Leon, Ph.D., Jennifer Dunlap, Tibor Kovacsovics, MD, Qiuying Liu, Amy Meacham, MS, Edward W Scott, Ph.D., William H Fleming, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 241.
https://doi.org/10.1182/blood.V118.21.241.241
Published: 2011
Journal Articles

AML Depends on VEGFR1 and Not VEGFR2 for Proliferation and Protection From Chemotherapy,

Swarna Bais, Ph.D., Elizabeth Wise, B.S., Eric M. Harris, DO, Amy Meacham, MS, Christopher R Cogle, M.D.
Journal: Blood
Blood (2011) 118 (21): 3598.
https://doi.org/10.1182/blood.V118.21.3598.3598
Published: 2011
Journal Articles

CECA Results in Improved Response Rates and Ability to Proceed to Stem Cell Transplantation in Adult Refractory or Relapsed Acute Myeloid Leukemia

Sukanthini Subbiah, MD, Randy A. Brown, MD, Myron N Chang, PhD, Christopher R Cogle, M.D., John W. Hiemenz, MD, W. Stratford May, MD, PhD, Jan Moreb, MD, Maxim Norkin, MD, PhD, John R. Wingard, MD, Baldeep Wirk, MD, Jack W Hsu, MD
Journal: Blood
Blood (2011) 118 (21): 4299.
https://doi.org/10.1182/blood.V118.21.4299.4299
Published: 2011
Journal Articles

Reinduction Chemotherapy for AML: Comparison Between CECA, High Dose Cytarabine and CLAG-M

Christina Escobar, B.S., Sukanthini Subbiah, MD, Maxim Norkin, MD, PhD, Helen Leather, BPharm, Ashley Richards, Pharm.D., Randy A. Brown, MD, W. Stratford May, John R. Wingard, MD, Jack W Hsu, MD, Christopher R Cogle, M.D.
Journal: Blood
Blood (2011) 118 (21): 4301.
https://doi.org/10.1182/blood.V118.21.4301.4301
Published: 2011
Journal Articles

AML Regression by Vascular Disruption with OXi4503 and Anti-Angiogenesis with Bevacizumab.

Gerard J Madlambayan, Ph.D., Amy Meacham, M.S., Koji Hosaka, Ph.D., Saad Mir, Marda Jorgensen, Edward W Scott, Ph.D., Dietmar W. Siemann, Ph.D., Christopher R. Cogle, M.D.
Journal: Blood
Blood (2009) 114 (22): 1031.
https://doi.org/10.1182/blood.V114.22.1031.1031
Published: 2009